Cronos Group Files 8-K on Financial Condition and Operations

Ticker: CRON · Form: 8-K · Filed: 2024-02-29T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, operations, 8-K

TL;DR

**Cronos Group just dropped an 8-K on their financials, so keep an eye out for the full details!**

AI Summary

Cronos Group Inc. filed an 8-K on February 29, 2024, to report its results of operations and financial condition. The filing indicates that the earliest event reported was also on February 29, 2024, and includes the company's business address at 111 Peter Street, Suite 300, Toronto, Ontario M5V 2H1. This report is filed under the Securities Exchange Act of 1934, with a Commission File Number of 001-38403.

Why It Matters

This filing provides investors with current information regarding Cronos Group Inc.'s financial performance and operational status, which can influence investment decisions.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial results and operations, not indicating any immediate high-risk events.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by Cronos Group Inc.?

The 8-K filing by Cronos Group Inc. is to report on the company's Results of Operations and Financial Condition, as stated in the 'ITEM INFORMATION' section.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on February 29, 2024, as indicated by 'Date of Report (Date of earliest event reported): February 29, 2024'.

What is the Commission File Number for Cronos Group Inc.?

The Commission File Number for Cronos Group Inc. is 001-38403, as listed in the filing.

Where are Cronos Group Inc.'s principal executive offices located?

Cronos Group Inc.'s principal executive offices are located at 111 Peter Street, Suite 300, Toronto, Ontario M5V 2H1.

Under which act is this current report filed?

This current report is filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

From the Filing

0001656472-24-000017.txt : 20240229 0001656472-24-000017.hdr.sgml : 20240229 20240229080627 ACCESSION NUMBER: 0001656472-24-000017 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240229 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 24698982 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 8-K 1 cron-20240229.htm 8-K cron-20240229 false CRONOS GROUP INC. 0001656472 Toronto Canada 001-38403 Ontario 0001656472 2023-11-08 2023-11-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 111 Peter Street, Suite 300 Toronto , Ontario M5V 2H1 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 416 ) 504-0004 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Shares, no par value CRON The NASDAQ Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02.    Results of Operations and Financial Condition. On February 29, 2024, Cronos Group Inc. (the “Company”) issued a press release announcing its financial results for its fourth quarter and full year ended December 31, 2023. A copy of the press release is attached as Exhibit 99.1 to and is incorporated by reference in this Current Report on Form 8-K. The information in this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),

View on Read The Filing